Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 204 citing SNIDERMAN: Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia.... (0.08 sec) 

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

- nih.gov [PDF] 
AR Tall - Journal of Clinical Investigation, 1990 - pubmedcentral.nih.gov
HDL are heterogeneous and can be classified into larger, less dense HDL2 or smaller, denser
HDL3. Although the major proportion of HDL is normally present in HDL3, individual variability
in HDL levels in human populations usually re- flects different amounts of HDL2- A major ...
Cited by 713 - Related articles - All 10 versions

Insulin resistance and cardiovascular disease

- nih.gov
HN Ginsberg - Journal of Clinical Investigation, 2000 - Am Soc Clin Investig
Insulin resistance means different things to different people. As other Perspectives in this series
make clear, insulin resistance can be seen as a molecular and genetic mystery involving defective
insulin signaling and glucose transport into cells. To me, on the other hand, insulin ...
Cited by 564 - Related articles - BL Direct - All 9 versions

Low density lipoprotein particle size and coronary artery disease

- ahajournals.org [PDF] 
H Campos, JJ Genest Jr, E Blijlevens, JR … - … , and Vascular Biology, 1992 - Am Heart Assoc
Decreased plasma low density lipoprotein (LDL) particle size has been associated with premature
coronary artery disease (CAD). We examined LDL particle size by 2-16% gradient gel electrophoresis
in 275 men with CAD (>75% cross-sectional-area stenosis) and 822 controls. Seven ...
Cited by 408 - Related articles - All 6 versions

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome


MD Grundy, M Scott - The American journal of cardiology, 1998 - Elsevier
The importance of high serum cholesterol, especially a high level of low-density lipoprotein
(LDL) cholesterol, as a risk factor for coronary artery disease is well established. Likewise, efficacy
for decreasing risk for coronary artery disease by LDL-lowering therapy has recently been ...
Cited by 386 - Related articles - BL Direct - All 5 versions

… hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes …

- annals.org [PDF] 
AD Sniderman, T Scantlebury, K … - Annals of internal …, 2001 - Am Coll Physicians
Abnormalities in insulin and glucose metabolism do not seem to entirely account for the high
frequency of cardiovascular disease in patients with type 2 diabetes mellitus. An important additional
factor may be hypertriglyceridemic hyperapoB, an atherogenic dyslipoproteinemia that is ...
Cited by 279 - Related articles - BL Direct - All 10 versions

Apoproteins B and Al and coronary artery disease in humans


JD Brunzell, AD Sniderman, JJ Albers, PO … - … , and Vascular Biology - Am Heart Assoc
1524-4636 Copyright © 1984 American Heart Association. All rights reserved. Print ISSN:
1079-5642. Online ISSN: 7272 Greenville Avenue, Dallas, TX 72514 Arteriosclerosis,
Thrombosis, and Vascular Biology is published by the American Heart Association.
Cited by 205 - Related articles - All 3 versions

Lipoprotein predictors of the severity of coronary artery disease in men and women

- ahajournals.org [PDF] 
MF Reardon, PJ Nestel, IH Craig, RW Harper - Circulation, 1985 - Am Heart Assoc
MICHAEL F. REARDON, PH.D.,t PAUL J. NESTEL, MD, IAN H. CRAIG, MD, AND RICHARD
W. HARPER, MD ... ABSTRACT In this study we examined the relationships between levels
of several components of ... LDL and to the cholesterol and apolipoprotein B ...
Cited by 192 - Related articles - All 7 versions

Quantitation of plasma apolipoproteins in the primary and secondary prevention of …

- annals.org
DJ Rader, JM Hoeg, HB Brewer - Annals of internal medicine, 1994 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Purpose: To review current knowledge
of apolipoprotein quantitation used in the clinical management of persons with or at risk ...
Cited by 183 - Related articles - BL Direct - All 3 versions

Relationship of plasma lipoprotein Lp (a) levels to race and to apolipoprotein B

- ahajournals.org [PDF] 
JR Guyton, GH Dahlen, W Patsch, JA Kautz, … - … , and Vascular Biology, 1985 - Am Heart Assoc
1524-4636 Copyright © 1985 American Heart Association. All rights reserved. Print ISSN:
1079-5642. Online ISSN: 7272 Greenville Avenue, Dallas, TX 72514 Arteriosclerosis,
Thrombosis, and Vascular Biology is published by the American Heart Association.
Cited by 188 - Related articles - All 3 versions

Coronary artery disease regression. Convincing evidence for the benefit of …

- ahajournals.org [PDF] 
HR Superko, RM Krauss - Circulation, 1994 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Convincing Evidence for the Benefit of Aggressive Lipoprotein Management
Cited by 171 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google